Tiziana Life Sciences Ltd (TLSA)

NASDAQ: TLSA · IEX Real-Time Price · USD

0.859

-0.027 (-3.00%)

At close: Jul 2, 2024, 4:00 PM

0.835

-0.024 (-2.79%)

After-hours: Jul 2, 2024, 7:25 PM EDT

Tiziana Life Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2016
Net Income	-17.69	-15.4	-23.42	-26.13	-9.32	Upgrade
Depreciation & Amortization	0.1	0.05	0.14	0.09	0.25	Upgrade
Share-Based Compensation	2.3	1.81	6.03	18.6	1.27	Upgrade
Other Operating Activities	-0.4	-6.08	-4.51	-3.89	1.01	Upgrade
Operating Cash Flow	-15.7	-19.62	-21.76	-11.34	-6.8	Upgrade
Capital Expenditures	0	0	-0.02	-0	-0	Upgrade
Acquisitions	-1	-2.68	0	-0.12	0	Upgrade
Change in Investments	-0.25	-1.32	0.15	0	0	Upgrade
Investing Cash Flow	-1.25	-4	0.13	-0.12	-0	Upgrade
Share Issuance / Repurchase	0.16	0	0.13	75.46	0	Upgrade
Debt Issued / Paid	-0.12	-0.06	-0.15	-0.11	1.68	Upgrade
Financing Cash Flow	0.04	-0.06	-0.02	75.35	1.68	Upgrade
Exchange Rate Effect	-0.03	-0.4	-1.98	1.74	0	Upgrade
Net Cash Flow	-16.91	-23.67	-21.66	63.89	-5.12	Upgrade
Free Cash Flow	-15.7	-19.62	-21.78	-11.34	-6.8	Upgrade
Free Cash Flow Per Share	-0.15	-0.19	-0.22	-0.17	-0.10	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).